Curriculum Vitae

PROF. DR. IVY CHUNG

Professor
  • Department of Pharmacology
    Faculty of Medicine
  • ivychung
  • 7967 3199

AREAS OF EXPERTISE

  • MOLECULAR PHARMACOLOGY
    Oncology, Molecular mechanism, Therapeutics

ACADEMIC QUALIFICATION

  • Postdoc (Harvard), (Bioperubatan)
    Harvard University, Cambridge
  • PhD (SUNY), (Pharmacology)
    State University of New York, Buffalo
  • B.Eng (Japan), (Kejuruteraan Bio)
    Tokyo Institute of Technology

ADMINISTRATIVE DUTIES

  • AHLI JAWATANKUASA PELAKSANA UMExpert UNIVERSITI MALAYA
    02 May 2023 - 01 May 2025 (University Malaya)
  • Director
    01 Jan 2023 - 31 Dec 2023 (Innovation and Enterprise Centre, Deputy Vice-Chancellor (Development))
  • Ahli Jawatankuasa Pembangunan UM-Industry Talent Management Framework
    28 Jun 2023 - 28 Sep 2023 (University Malaya)
  • Task Force Member
    17 Sep 2021 - 08 Aug 2023 (University Malaya)
  • Director
    01 Jan 2021 - 31 Dec 2022 (Innovation and Enterprise Centre, Deputy Vice-Chancellor (Development))
  • Coordinator for Industry Partners Platform, InnnovateUM.
    13 Aug 2020 - 12 Aug 2021 (University Malaya)
  • Industry & Community Liason Officer, ICLO
    17 Jun 2019 - 16 Jun 2021 (University Malaya)
  • Committee, Task Force Pelan Strategik Jaringan Antarabangsa Universiti Awam
    30 May 2019 - 29 May 2021 (National)
  • Coordinator
    16 Apr 2020 - 15 Apr 2021 (Department of Pharmacology, Faculty of Medicine)
  • Deputy Dean of Research Cluster
    01 Dec 2020 - 31 Dec 2020 (Health and Well-Being Cluster, Deputy Vice-Chancellor (Research and Innovation))
  • Deputy Dean of Research Cluster
    01 Dec 2018 - 30 Nov 2020 (Health and Well-Being Cluster, Deputy Vice-Chancellor (Research and Innovation))
  • Manager, Translational Core Laboratory, Faculty of Medicine
    01 Oct 2019 - 30 Sep 2020 (Faculty)
  • Manager, Faculty of Medicine Supply Store
    01 Oct 2019 - 30 Sep 2020 (Faculty)
  • Committee, MyKidney Program, Department of Higher Education, Ministry of Education
    12 Jun 2018 - 11 Jun 2020 (National)
  • Committee, Program CEO@Faculty 2.0 cycle 2, Ministry of Education
    15 Mar 2018 - 14 Mar 2020 (National)
  • Deputy Dean
    01 Jul 2018 - 30 Sep 2018 (Wellness Research Kluster, Deputy Vice-Chancellor (Research and Innovation))
  • Deputy Dean
    01 Jan 2018 - 30 Jun 2018 (Wellness Research Kluster, Deputy Vice-Chancellor (Research and Innovation))
  • Ahli Jawatankuasa Fasiliti Gunasama Penyelidikan dan Perkhidmatan (JFGPP), Fakulti Perubatan
    03 Jan 2017 - 31 Dec 2018 (University Malaya)
  • Coordinator for Translational Core Laboratory
    20 Jan 2014 - 31 Dec 2018 (Dean Office, Faculty of Medicine)
  • Penyelaras Penyelidikan (Antarabangsa)
    01 Jul 2016 - 31 Dec 2018 (University Malaya)
  • Committee, CEO@Faculty Program 2.0 cycle 2 Bootcamp, MOE
    15 Mar 2018 - 06 May 2018 (National)
  • Committee, CEO@Faculty 2.0 cycle 2, MOE Interview session
    15 Mar 2018 - 25 Apr 2018 (National)
  • Jawatankuasa Penasihat Accelerator Diagnostik Sains Hayat Bangunan I2U UM
    26 Feb 2016 - 25 Feb 2018 (University Malaya)
  • AJK Penilai Pengkomersilan Universiti Malaya
    04 Jan 2016 - 03 Jan 2018 (University Malaya)
  • Deputy Dean
    03 Jan 2017 - 31 Dec 2017 (Wellness Research Kluster, Deputy Vice-Chancellor (Research and Innovation))
  • Technical Committee Member for Bioinspire Program
    24 Feb 2016 - 31 Dec 2017 (University Malaya)
  • Deputy Dean
    10 Aug 2015 - 31 Dec 2016 (Wellness Research Kluster, Deputy Vice-Chancellor (Research and Innovation))
  • Ahli Lembaga Penasihat Advanced Imaging Unit
    02 Dec 2013 - 31 Dec 2016 (Dean Office, Faculty of Medicine)
  • AJK Penilaian bagi Permohonan Geran Penyelidikan, IPPP
    04 Mar 2015 - 31 Dec 2016 (University Malaya)
  • Ahli Jawatankuasa Makmal Gunasama Fakulti Perubatan
    24 Jan 2014 - 31 Dec 2016 (Dean Office, Faculty of Medicine)
  • Technical & Logistic Committee, UM Research Carnival 2015
    04 Sep 2015 - 10 Oct 2015 (University Malaya)
  • Coordinator for Biomedical Sciences undergraduate program, MBEB2105 and MDEB4101
    27 Jan 2014 - 31 Jan 2015 (Department of Pharmacology, Faculty of Medicine)
  • Program Coordinator (Penyelaras Program) for Jawatankuasa Ijazah Tinggi Fakulti Perubatan (JKITFP)
    14 Aug 2011 - 31 Dec 2014 (Department of Pharmacology, Faculty of Medicine)
  • Ahli Jawatankuasa "Research Strategic Planning for Faculty of Medicine"
    01 Jun 2013 - 31 May 2014 (Dean Office, Faculty of Medicine)
  • Coordinator for Department of Pharmacology Journal Club
    21 Jul 2011 - 31 Dec 2013 (Department of Pharmacology, Faculty of Medicine)
  • Academic Advisor for Phase 2 MBBS students
    01 Aug 2012 - 01 Aug 2013 (Department of Pharmacology, Faculty of Medicine)

MEMBERSHIPS

  • SIGMA XI FULL MEMBER, MEMBER
    Since 2022 (International)
  • MEMBER, MAJLIS PROFESOR NEGARA, MEMBER
    Since 2022 (National)
  • KETUA SECRETARIAT, PROGRAM PUSAT SEHENTI INNOVASI @UM, SECRETARY
    2021 to 2023 (University)
  • JOURNAL OF HEALTH AND TRANSLATIONAL MEDICINE (JUMMEC), EDITORIAL BOARD
    2013 to 2023 (International)
  • MEMBER, ASSOCIATION OF DIGITAL HEALTH MALAYSIA, MEMBER
    2022 to 2022 (National)
  • TASK FORCE UM HEALTH PROJECT - FACILITIES, MEMBER
    2021 to 2022 (University)
  • AHLI JAWATANKUASA PENYELARASAN PETUNJUK PRESTASI UTAMA (KPI) DAN OBJEKTIF KUALITI UM, COMMITTEE MEMBER
    2021 to 2022 (University)
  • AHLI JAWATANKUASA KERJA TIMES HIGHER EDUCATION IMPACT RANKINGS (THE IR), COMMITTEE MEMBER
    2021 to 2022 (University)
  • JAWATANKUASA KERJA INDUSTRY@RU, COMMITTEE MEMBER
    2021 to 2022 (National)
  • WAKIL MAJIKAN JAWATANKUASA KESELAMATAN & KESIHATAN PEKERJAAN (JKKP), COMMITTEE MEMBER
    2021 to 2022 (University)
  • HEALTH SCIENCES SCIENTIFIC COMMITTEE, COMMITTEE MEMBER
    2021 to 2021 (International)
  • ACTION LAB FOR UM TRANSFORMATION PLAN (EXCEL IN RESEARCH EMINENCE), MEMBER
    2021 to 2021 (University)
  • KETUA SUSTAINABLE DEVELOPMENT GOALS (SDGS) FOR TIMES HIGHER EDUCATION IMPACT RANKINGS, COMMITTEE MEMBER
    2020 to 2021 (University)
  • MALAYSIAN ASSOCIATION OF PHARMACOLOGY AND PHYSIOLOGY, COMMITTEE MEMBER
    2014 to 2021 (University)
  • ASSOCIATION FOR CANCER RESEARCH (AACR), MEMBER
    2005 to 2021 (International)

AWARD AND STEWARDSHIP

  • Mentor, Asia Pacific Women in Leadership (APWiL) Program
    Association of Pacific Rim Universities, 2023 (International)
  • Outstanding Women Researcher in Pharmacology
    Venus International Foundation, 2023 (International)
  • Sigma Xi Full Member
    Sigma Xi Scientific Research Honor Society, 2022 (International)
  • Certified Innovation Professional
    Global Innovation Management Institute, 2022 (International)
  • Innovation Technology Commercialization Professional
    International Technology Transfer Network, 2022 (International)
  • Malaysia Intellectual Property Elites
    Majlis Tindakan Pengguna Nasional, 2022 (National)
  • Asia Pacific Women in Leadership Mentor
    Association of Pacific Rim Universities (APRU), 2022 (International)
  • APEC-Australia Women in Research Fellowship
    APEC-Australia, 2022 (International)
  • Expert Panel, US-ASEAN Digital Entrepreneurship Internship Webinar
    US-ASEAN Council, 2021 (International)
  • Expert panel for Dana Penyelidikan Kementerian Pengajian Tinggi, Malaysia
    KPT Malaysia, 2021 (National)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2021 (University)
  • Expert panel, PATHw Virtual Asia Roundtable on "Reimagining healthier workplaces in Asia"
    Novartis Healthcare Phillipines, 2020 (International)
  • Panel of Expert for First in Human for Clinical Trial Import License
    National Pharmaceutical Regulatory Agency Malaysia, 2020 (National)
  • Youth Editorial Board Member, Cancer Drug Resistance
    OAE Publishing Inc, 2020 (International)
  • Vice Director for National Cheng Kung University Overseas Hub in Malaysia
    National Cheng Kung University, Taiwan, 2020 (International)
  • Kwong Soke Chee, Runner-up, University Malaya 3 Minutes Thesis Competition
    Universiti Malaya, 2019 (University)
  • Kwong Soke Chee, 3rd Place Winner, UM 3 minutes thesis competition
    University Malaya, 2019 (University)
  • Director, myKidney Program
    Jabatan Pendidikan Tinggi, Kementerian Pendidikan Malaysia, 2019 (Community)
  • Expert Panel, 6th ASEAN Future Leaders Summit (AFLES)
    AKEPT Malaysia, 2017 (International)
  • CEO@Faculty 2.0 ?Coached by the PRO? Program Fellow
    Ministry of Higher Education, 2017 (National)
  • 14th Asia-Pacific Oncologists Annual Meeting, Melbourne, Australia Organizing Committee
    Journal of Cancer Science & Therapy, 2017 (International)
  • University of Malaya Excellent Lecturer Award
    University of Malaya, 2017 (University)
  • Expert Panel for Italian Ministry of Health Research Grant
    MOH Italy, 2016 (International)
  • Organizing Committee for 13th Asia-Pacific Oncologists Annual Meeting
    Editors of Journal of Cancer Science & Therapy, 2016 (International)
  • Kavita Subramaniam, Novartis Next-Generation Scientist Program
    Novartis International AG, 2015 (International)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2015 (University)
  • The Young Einstein Decade Y2K7 Award
    Roswell Park Cancer Institute, 2007 (University)

PUBLICATIONS

Article in Journal
WoS
  1. Chen, Jzit Weii; Liew, Fong Fong; Tan, Hsiao Wei; Misran, Misni; Chung, Ivy (2023). Cholesterol-linoleic acid liposomes induced extracellular vesicles secretion from immortalized adipose-derived mesenchymal stem cells for in vitro cell migration, ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 51(1), 346-360. doi:10.1080/21691401.2023.2237534
  2. Chew, Boon Cheng; Liew, Fong Fong; Tan, Hsiao Wei; Chung, Ivy (2022). Chemical Advances in Therapeutic Application of Exosomes and Liposomes, CURRENT MEDICINAL CHEMISTRY. 29(25), 4445-4473. doi:10.2174/0929867329666220221094044
  3. Fong, Stephanie Sally; Foo, Yiing Yee; Saw, Wen Shang; Leo, Bey Fen; Teo, Yin Yin; Chung, Ivy; Goh, Boon Tong; Misran, Misni; Imae, Toyoko; Chang, Chia-Ching; Chung, Lip Yong; Kiew, Lik Voon (2022). p Chitosan-Coated-PLGA Nanoparticles Enhance the Antitumor and Antimigration Activity of Stattic - A STAT3 Dimerization Blocker, INTERNATIONAL JOURNAL OF NANOMEDICINE. 17, 137-150. doi:10.2147/IJN.S337093
  4. Mozihim, Azilleo Kristo; Chung, Ivy; Said, Nur Akmarina B. M.; Abd Jamil, Amira Hajirah (2022). Reprogramming of Fatty Acid Metabolism in Gynaecological Cancers: Is There a Role for Oestradiol?, METABOLITES. 12(4). doi:10.3390/metabo12040350
  5. Omar, Intan Sofia; Abd Jamil, Amira Hajirah; Adenan, Noor Azmi Mat; Chung, Ivy (2022). MPA alters metabolic phenotype of endometrial cancer-associated fibroblasts from obese women via IRS2 signaling, PLOS ONE. 17(7). doi:10.1371/journal.pone.0270830
  6. Omar, Intan Sofia; Adenan, Noor Azmi Mat; Godoy, Alejandro; Teo, Ik Hui; Gunasagran, Yogeeta; Chung, Ivy (2022). Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 628, 133-140. doi:10.1016/j.bbrc.2022.08.088
  7. Paramanantham, Yogaambikai; Chung, Ivy; Said, Nur Akmarina B. M. (2022). The role of tumour microenvironment-driven miRNAs in the chemoresistance of muscle-invasive bladder cancer-a review, UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 40(4), 133-148. doi:10.1016/j.urolonc.2022.01.013
  8. Tsai, Yao-Tsung; Li, Chih-Yi; Huang, Yen-Hua; Chang, Te-Sheng; Lin, Chung-Yen; Chuang, Chia-Hsien; Wang, Chih-Yang; Anuraga, Gangga; Chang, Tzu-Hao; Shih, Tsung-Chieh; Lin, Zu-Yau; Chen, Yuh-Ling; Chung, Ivy; Lee, Kuen-Haur; Chang, Che-Chang; Sung, Shian-Ying; Yang, Kai-Huei; Tsui, Wan-Lin; Yap, Chee-Voon; Wu, Ming-Heng (2022). Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts, ONCOGENE. . doi:10.1038/s41388-022-02309-7
  9. Wong, Li Ping; Alias, Haridah; Hashim, Megat Mohamad Amirul Amzar Megat; Lee, Hai Yen; AbuBakar, Sazaly; Chung, Ivy; Hu, Zhijan; Lin, Yulan (2022). Acceptability for COVID-19 vaccination: perspectives from Muslims, HUMAN VACCINES & IMMUNOTHERAPEUTICS. . doi:10.1080/21645515.2022.2045855
  10. Chung, I., Zhou, K., Barrows, C., Banyard, J., Wilson, A., Rummel, N., . . . Zetter, B. R. (2021). Unbiased Phenotype-Based Screen Identifies Therapeutic Agents Selective for Metastatic Prostate Cancer. Frontiers in Oncology, 10, 14. doi: 10.3389/fonc.2020.594141
  11. Morrissey, K., Chung, I., Morse, A., Parthasarath, S., Roebuck, M., Tan, M., . . . Frostick, S. (2021). The Effects of Air Quality on Hospital Admissions for Chronic Respiratory Diseases in Petaling Jaya, Malaysia, 2013-2015. Atmosphere, 12(8), 10. doi: 10.3390/atmos12081060
  12. Nalairndran, G., Chung, I., Razack, A. H. A., Chung, F. F. L., Hii, L. W., Lim, W. M., . . . Leong, C. O. (2021). Inhibition of Janus Kinase 1 synergizes docetaxel sensitivity in prostate cancer cells. Journal of Cellular and Molecular Medicine, 25(17), 8187-8200. doi: 10.1111/jcmm.16684
  13. Phang, M. W. L., Lew, S. Y., Chung, I., Lim, W. K. S., Lim, L. W., & Wong, K. H. (2021). Therapeutic roles of natural remedies in combating hereditary ataxia: A systematic review. Chinese Medicine, 16(1), 22. doi: 10.1186/s13020-020-00414-x
  14. Wong, L. P., Alias, H., Fuzi, A. A. M., Omar, I. S., Mohamad Nor, A., Tan, M. P., . . . Chung, I. (2021). Escalating progression of mental health disorders during the COVID-19 pandemic: Evidence from a nationwide survey. PloS one, 16(3), 14. doi: 10.1371/journal.pone.0248916
  15. Kwa, Y. C., Tan, Y. F., Foo, Y. Y., Leo, B. F., Chung, I., Kiew, L. V., . . . Chung, L. Y. (2020). Improved delivery and antimetastatic effects of Stattic by self-assembled amphiphilic pendant-dendron copolymer micelles in breast cancer cell lines. Journal of Drug Delivery Science and Technology, 59, 11. doi: 10.1016/j.jddst.2020.101905
  16. Kwong, S. C., Abd Jamil, A. H., Rhodes, A., Taib, N. A., & Chung, I. (2020). Fatty acid binding protein 7 mediates linoleic acid-induced cell death in triple negative breast cancer cells by modulating 13-HODE. Biochimie, 179, 23-31. doi: 10.1016/j.biochi.2020.09.005
  17. Ng, F. L., Phang, S. M., Lan, B. L., Kalavally, V., Thong, C. H., Chong, K. T., . . . Fisher, A. C. (2020). Optimised spectral effects of programmable LED arrays (PLA)s on bioelectricity generation from algal-biophotovoltaic devices. Scientific Reports, 10(1), 13. doi: 10.1038/s41598-020-72823-9
  18. Nor, W., Chung, I., & Said, N. (2021). MicroRNA-548m Suppresses Cell Migration and Invasion by Targeting Aryl Hydrocarbon Receptor in Breast Cancer Cells. Oncology Research, 28(6), 615-629. doi: 10.3727/096504020x16037933185170
  19. Suk, V. R. E., Chung, I., Misran, M. (2020). PEGylated Oleic Acid-Lecithin Liposomes (POLL) for Anticancer Drug Delivery. Sains Malaysiana, 49(1), 19-27. doi: 10.17576/jsm-2020-4901-03
  20. Suk, V. R. E., Chung, I., & Misran, M. (2020). Mixed Oleic Acid-Erucic Acid Liposomes as a Carrier for Anticancer Drugs. Current Drug Delivery, 17(4), 292-302. doi: 10.2174/1567201817666200210122933
  21. Wong, L. P., Alias, H., Bhoo-Pathy, N., Chung, I., Chong, Y. C., Kalra, S., & Shah, Z. (2020). Impact of migraine on workplace productivity and monetary loss: a study of employees in banking sector in Malaysia. Journal of Headache and Pain, 21(1). doi: 10.1186/s10194-020-01144-z
  22. Kwong, S. C., Abd Jamil, A. H., Rhodes, A., Taib, N. A., Chung, I. (2019). Metabolic role of fatty acid binding protein 7 in mediating triple-negative breast cancer cell death via PPAR-alpha signaling. Journal of Lipid Research, 60(11), 1807-1817. doi:10.1194/jlr.M092379
  23. Lai, S. L., Tan, M. L., Hollows, R. J., Robinson, M., Ibrahim, M., Margielewska, S., . . . Paterson, I. C. (2019). Collagen Induces a More Proliferative, Migratory and Chemoresistant Phenotype in Head and Neck Cancer via DDR1. Cancers, 11(11), 16. doi: 10.3390/cancers11111766
  24. Cheong, J. E., Zaffagni, M., Chung, I., Xu, Y. J., Wang, Y. Q., Jernigan, F. E., . . . Sun, L. J. (2018). Synthesis and anticancer activity of novel water soluble benzimidazole carbamates. European Journal of Medicinal Chemistry, 144, 372-385. doi:10.1016/j.ejmech.2017.11.037
  25. Wu, Y. S., Chung, I., Wong, W. F., Masamune, A., Sim, M. S., Looi, C. Y. (2017). Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells. Biochimica Et Biophysica Acta-General Subjects, 1861(2), 296-306.
  26. Subramaniam, K. S., Omar, I. S., Kwong, S. C., Mohamed, Z., Woo, Y. L., Adenan, N. A. M., Chung, I. (2016). Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway, American Journal of Cancer Research. 6(2200-213), Article
  27. Varatharajan, R., Lim, L. X., Tan, K., Tay, C. S., Teoh, Y. L., Akhtar, S. S., Rupeshkumar, M., Chung, I., Abdullah, N. A., Banik, U., Dhanaraj, S. A., Balakumar, P. (2016). Effect of edaravone in diabetes mellitus-induced nephropathy in rats, Korean Journal of Physiology Pharmacology. 20(4333-340), Article
  28. Wu, Y. S., Looi, C. Y., Subramaniam, K. S., Masamune, A., Chung, I. (2016). Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification, Oncotarget. 7(2436719-36732), Article
  29. Banyard, J., Chung, I., Migliozzi, M., Phan, D. T., Wilson, A. M., Zetter, B. R., Bielenberg, D. R. (2014). Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer, Bmc Cancer. 14(15), Article
  30. Lee, M. L., Chung, I., Fung, S. Y., Kanthimathi, M. S., Tan, N. H. (2014). Antiproliferative Activity of King Cobra (Ophiophagus hannah) Venom l-Amino Acid Oxidase, Basic Clinical Pharmacology Toxicology. 114(4), 336-343
  31. Lee, M. L., Fung, S. Y., Chung, I., Pailoor, J., Cheah, S. H., Tan, N. H. (2014). King Cobra (Ophiophagus hannah) Venom L-Amino Acid Oxidase Induces Apoptosis in PC-3 Cells and Suppresses PC-3 Solid Tumor Growth in a Tumor Xenograft Mouse Model, International Journal of Medical Sciences. 11(6), 593-601
  32. Banyard, J., Chung, I., Wilson, A. M., Vetter, G., Le Bechec, A., Bielenberg, D. R., Zetter, B. R. (2013). Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model, Scientific Reports. 3, 12
  33. Godoy, A. S., Chung, I., Montecinos, V. P., Buttyan, R., Johnson, C. S., Smith, G. J. (2013). Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate, American Journal of Physiology-Endocrinology and Metabolism. 304(11), E1131-E1139
  34. Subramaniam, Kavita S.; Tham, Seng Tian; Mohamed, Zahurin; Woo, Yin Ling; Adenan, Noor Azmi Mat; Chung, Ivy (2013). Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells, PLOS ONE. 8(7). doi:10.1371/journal.pone.0068923
  35. Varatharajan, R., Sattar, M. Z. A., Chung, I., Abdulla, M. A., Kassim, N. M., Abdullah, N. A. (2013). Antioxidant and pro-oxidant effects of oil palm (Elaeis guineensis) leaves extract in experimental diabetic nephropathy: a duration-dependent outcome, Bmc Complementary and Alternative Medicine. 13, 13
  36. Zhang, Y. Q., Yan, W., Collins, M. A., Bednar, F., Rakshit, S., Zetter, B. R., Stanger, B. Z., Chung, I., Rhim, A. D., di Magliano, M. P. (2013). Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance, Cancer Research. 73(20), 6359-6374
  37. Olsen, R. R., Chung, I., Zetter, B. R. (2012). Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo, Amino Acids. 42(2-3), 549-558
Scopus
  1. Kwa Y.C., Anasamy T., Foo Y.Y., Leo B.F., Chung I., Kiew L.V., Chung L.Y. (2022). Preparation and Characterization of Stattic-Loaded Albumin Nanoparticles for Antimetastatic Cancer Treatment, Drug Delivery Letters. 12(1), 74-83. doi:10.2174/2210303112666220330115110
  2. Yap, C., Subramaniam, K., Khor, S., Chung, I. (2017). Annonacin exerts antitumor activity through induction of apoptosis and extracellular signal-regulated kinase inhibition. Pharmacognosy Research, 9(4), 378-383. doi: 10.4103/pr.pr_19_17
  3. Subramaniam, K. S., Wong, M. S., Woo, Y. L., Mat Adenan, N. A., Mohamed, Z., Chung, I. (2013). Preliminary study on the occurrence of PTEN and PIK3CA gene mutations in endometrial cancer among Malaysian women, Journal of the University of Malaya Medical Centre. 16(1), 1-5
Others
  1. Fong SS, Foo YY, Saw WA, Leo BF, Teo YY, Chung I, Goh BT, Misran M, Imae T, Chang CC, Chung LY and Kiew LV (2022) Chitosan-coated-PLGA nanoparticles enhance the antitumor and antimigration activity of Stattic a STAT3 dimerization blocker. International Journal of Nanomedicine 17:137-150
  2. Mozihim A, Chung I, Mohd Said NA and Abd Jamil AH (2022) Reprogramming of fatty acid metabolism and gynaecological cancers: Is there a role of oestradiol? Metabolites 12(4):350.
  3. Omar IS, Abd Jami AH, Mat Adenan NA and Chung I (2022) MPA alters phenotype of endometrial cancer-associated fibroblasts from obese women via IRS2 signaling. PLOS ONE 17(7):e0280830
  4. Paramanathan, Y., Chung, I., Mohd Said, N.A. (2022) The role of tumor microenvironment-driven miRNAs in the chemoresistance of muscle-invasive bladder cancer a review. Urologic Oncology: Seminars and Original Investigations 40(4):133-148.
  5. Ibrahim, A., Chong, M. C., Khoo, S., Wong, L. P., Chung, I., & Tan, M. P. (2021). Virtual Group Exercises and Psychological Status among Community-Dwelling Older Adults during the COVID-19 Pandemic A Feasibility Study. Geriatrics, 6(1), 31. https://www.mdpi.com/2308-3417/6/1/31
  6. Varatharajan R, Lim LX, Tan K, Tay CS, Teoh YL, Akhtar SS, Rupeshkumar M, Chung I, Abdullah NA, Banik U, Dhanaraj SA, Balakumar P. 2015. Effect of Edaravone in diabetes mellitus-induced nephropathy in rats. Korean Journal of Physiology and Pharmacology
  7. Varatharajan V, Saravanan J, Chung I, Abdullah NA. 2015. Overview of Diabetic Nephropathy. PTB Reports 1(3): 104-110.
  8. Banyard J, Chung I, Migliozzi M, Phan DT, Wilson AM, Zetter BR and Bielenberg D. 2014. Identification of genes regulating micration and invasion using a new model of metastatic prostate cancer. BMC Cancer 14 (1):387.
  9. Lee ML, Fung SY, Chung I, Pailoor J, Cheah SH and Tan NH. King cobra (Ophiophagus Hannah) venom L-amino acid oxidase induces apoptosis in PC-3 cells and suppresses PC-3 solid tumor growth in a tumor xenograft mouse model.2014.International Journal of Medical Sciences 11:593-601.
  10. Rachelle R. Olsen, Ivy Chung and Bruce R. Zetter.2012. Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo. Amino Acids.
  11. Spivey, K.A., Chung, I., Banyard, J., Adini, I., Feldman, H.A., Zetter, B.R. (2012). A role of collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis. Oncogene 31 (18):2362-72.
  12. Chung I, Holleman A*, Olsen RR, Kwak B and Zetter BR. 2011. miR-135a as potential biomarker for development of taxane resistance in human cancer. Oncogene 30(43):4386-4398 (*shared first authorship)
  13. Holleman. A.*, Chung, I.,* Olsen, R.R., Kwak, B., Zetter, B.R. (2011) miR-135a as potential biomarker for development of taxane resistance in human cancer. (*, shared first authorship). Oncogene 30 (43):4386-4398
  14. Rummel N, Chung I and Shaikh Badar. 2011. Determination of albendazole, fenbendazole, and their metabolites in mice plasma by high performance liquid chromatography. Journal of Liquid Chromatography & Related Technologies 34(18):2211-2223.
  15. Rummel, N., Chung, I., Shaikh, B. (2011) Determination of albendazole, fenbendazole and their metabolites in mice plasma by high performance liquid chromatography. J. Pharmaceutical and Biomedical Analysis 34 (18): 2211-2223
  16. Spivey KA, Chung I, Banyard J, Adini I, Feldman HA and Zetter BR. 2011. A role of collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis. Oncogene Oct 3 (Epub ahead of print)
  17. Johnson CS, Chung I and Trump DL. 2010. Epigenetic silencing of CYP24 in the tumor microenvironment. Journal of Steroid Biochemistry and Molecular Biology 121(1-2):338-42.
  18. Johnson, C.S., Chung, I., Trump, D.L. (2010) Review: Epigenetic silencing of CYP24 in tumor microenvironment. Journal of Steroid Biochemistry and Molecular Biology 121(1-2):338-42
  19. Patel N, Chatterjee SK, Vrbanac V, Chung I, Mu CJ, Olsen RR, Waghorne C and Zetter BR. 2010. Rescue of paclitaxel sensitivity by repression of prohibitin 1 in drug-resistant cancer cells. Proceedings of the National Academy of Sciences 107(6):2503-2508
  20. Patel, N., Chatterjee, S.K., Vrbanac, V., Chung, I., Mu, C.J., Olsen, R.R., Waghorne, C., Zetter, B.R. (2010) Rescue of paclitaxel sensitivity by repression of prohibitin 1 in drug-resistant cancer cells. Proceedings of the National Academy of Sciences 107(6):2503-2508
  21. Chung, I., Han, G.Z., Seshadri, M., Gillard, B.M., Yu, W.D., Foster, B.A., Trump, D.L., Johnson, C.S. (2009) Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo. Cancer Research 69(3):967-975
  22. Adachi T, Nakagawa H, Chung I, Hagiya Y, Hoshijima K, Noguchi N, Kuo MT and Ishikawa T. 2007. Nrf2-dependent and independent nduction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. Journal of Experimental Therapeutics and Oncology 6(4):335-348.
  23. Adachi, T., Nakagawa, H., Chung, I., Hagiya, Y., Hoshijima, K., Noguchi, N., Kuo, M.T., Ishikawa, T. (2007) Nrf2-dependent and independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. Journal of Experimental Therapeutics and Oncology 6(4):335-348
  24. Chung I, Yu WD, Karpf AR, Flynn G, Bernardi RJ, Modzelewski RA, Johnson CS and Trump DL. 2007. Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments. J. Steroid Biochemistry and Molecular Biology 103(3-5):768-70.
  25. Chung, I., Karpf, A.R., Muindi, J.R., Conroy, J.M., Nowak, N.J., Johnson, C.S., Trump, D.L. (2007) Epigenetic silencing of CYP24 in tumor-derived endothelial cells contributes to selective growth inhibition by calcitriol. Journal of Biological Chemistry 282(12):8704-14
  26. Chung, I., Yu, W.D., Karpf, A.R., Flynn, G., Bernardi, R.J., Modzelewski, R.A., Johnson, C.S., Trump, D.L. (2007) Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments. J. Steroid Biochemistry and Molecular Biology 103(3-5):768-70
  27. Flynn, G., Chung, I., Yu, W.D., Romano, M., Modzelewski, R.A., Johnson, C.S., Trump, D.L. (2007) Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis. Oncology 70(6):447-457
  28. Chung I, Wong MK, Flynn G, Yu WD, Johnson CS and Trump DL. 2006. Differential anti-proliferative effects of calcitriol on tumor-derived and Matrigel-derived endothelial cells. Cancer Research 66: 8565-8573.
  29. Chung, I., Wong, M.K., Flynn, G., Yu, W.D., Johnson, C.S., Trump, D.L. (2006) Differential antiproliferative effects of calcitriol on tumor-derived and Matrigel-derived endothelial cells. Cancer Research 66: 8565-8573
  30. Flynn G, Chung I, Yu WD, Romano M, Modzelewski RA, Johnson CS and Trump DL. 2006. Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis. Oncology 70(6):447-457.
Chapter in Books
  1. Chung, I. Tumor fibroblasts: pivotal players in drug resistance. In: Morais, C. ed. Advances in drug resistance research, Nova Science Publishers, N.Y., USA. (In Press)

RESEARCH PROJECT

National
  1. 2023 - 2026, Fundamental Research Grant Scheme (FRGS)
    Deciphering The Enigmatic Role Of Mir-660-5p/hdac2 Axis In Lipid Metabolic Reprogramming In Obesity-associated Colorectal Cancer ( Principal Investigator(PI))
  2. 2021 - 2025, Fundamental Research Grant Scheme (FRGS)
    Unraveling The Role Of Endometrial Cancer Fibroblasts In Lipogenic-driven Hormone Resistance In Obese Women Using Metabolic Fingerprinting Approach ( Co-Researcher)
  3. 2022 - 2025, Fundamental Research Grant Scheme (FRGS)
    The Upregulation Of Microrna 146b-5p In The Metabolic Crosstalk Between Macrophage And Cholesterol Pathway In Bladder Cancer Progression: A Mechanistic Study ( Co-Researcher)
  4. 2019 - 2024, Long Term Research Grant Scheme (LRGS)
    Mrun : Discovery Of Fecal Cancer Biomarkers And Its Correlation With Gut Microbiota And Dietary Profiles In Different States Of Obesity And Obesity-associated Colorectal Cancer ( Principal Investigator(PI))
  5. 2023 - 2024, RU Geran - UMCIC
    Um Deep Tech Accelerator Program ( Principal Investigator(PI))
  6. 2019 - 2023, Long Term Research Grant Scheme (LRGS)
    Mrun : Linking Obesity To Cancer: An Integrative Study From Molecule To Society ( Principal Investigator(PI))
  7. 2019 - 2023, Long Term Research Grant Scheme (LRGS)
    Mrun : Identification Of Risk Factors Associated With Cancer Prognosis, Disease Survival And Recurrence In Obese Individuals ( Principal Investigator(PI))
  8. 2019 - 2022, Others MOHE - Top 100 (IIRG)-HWB
    Mirna Regulation Of Fdft1 In Mediating Chemoresistance In Bladder Cancer ( Co-Researcher)
  9. 2019 - 2022, RU Geran - Fakulti Program
    Protective Effect Of Culinary And Medicinal Mushrooms, Hericium Erinaceus (bull.:fr) Pers. And Lignosus Rhinocerotis (cooke) Ryvarden Against Oxidative Damage In An In Vitro Model Of Inherited Ataxia - Expanding Our Understanding On Regulation Of Mitochondrial Function ( Co-Researcher)
  10. 2020 - 2022, RU Geran
    Comparative Cellular Signaling Activated in Cancer-Associated Fibroblasts Interaction with Cancer Cells ( Principal Investigator(PI))
  11. 2020 - 2021, Covid-19 Special Research Grant
    Covid 19: Mental Wellbeing For Community ( Principal Investigator(PI))
  12. 2016 - 2020, Fundamental Research Grant Scheme (FRGS)
    The Role Of Fibroblast On Microrna Regulation Of Epithelial To Mesenchymal Transition-mediated Cisplatin Resistance In Bladder Cancer ( Co-Researcher)
  13. 2017 - 2020, Fundamental Research Grant Scheme (FRGS)
    Nano-stealthing The Stat3-blocker For Improved Anti-metastatic Activity: Mechanistic And Pharmacological Studies ( Co-Researcher)
  14. 2017 - 2020, UM Grant - Frontier Research Grant
    Regulation Of Cell Motility By Cancer-associated Fibroblasts To Induce Stemness Traits In Endometrial Cancer ( Principal Investigator(PI))
  15. 2017 - 2019, Bantuan Kecil Penyelidikan (BKP)
    Metabolic role of fatty acid transporters (CD36) in endometrial cancer progression among obese and diabetic patients ( Co-Researcher)
  16. 2018 - 2019, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness)
    Longhouse And Communal Living Promoting Healthy Ageing In Bario, Sarawak ( Co-Researcher)
  17. 2014 - 2018, Fundamental Research Grant Scheme (FRGS)
    Differential Pharmacological Actions Of Medroxyprogestrone Acetate (mpa) On Benign- And Cancer-associated Endometrial Fibroblasts ( Principal Investigator(PI))
  18. 2014 - 2017, Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness)
    Primary Cell Culture Models For Cancer Drug Discovery ( Principal Investigator(PI))
  19. 2015 - 2017, Geran Penyelidikan Universiti Malaya (UMRG) - AFR (Frontier Science)
    Investigating the role of miR-548m in epithelial-mesenchymal transition of cancer metastasis ( Co-Researcher)
  20. 2012 - 2015, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness)
    Stromal Fibroblasts As Mediators Of Chemoresistance In Oral Carcinoma Cells ( Co-Researcher)
  21. 2013 - 2015, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness)
    Role Of Cancer-associated Fibroblasts In The Progression Of Endometrial Cancer ( Principal Investigator(PI))
  22. 2021 - 2022, Others MOHE
    Malaysian University Youth Entrepreneurship program (MyUniYEP), Universiti Malaysia Kelantan ( Co-Researcher)
  23. 2019 - 2021, Long Term Research Grant Scheme (LRGS)
    Linking obesity to cancer: An integrative study from molecule to society ( Principal Investigator(PI))
  24. 2019 - 2021, RU Grant- Faculty Program
    Protective effect of culinary and medicinal mushrooms, Hericium Erinaceus and Lignosus Rhinocerotis against oxidative damage in an vitro model of inherited ataxia ( Consultant)
  25. 2019 - 2021, Fundamental Research Grant Scheme (FRGS)
    Anticancer activity of hyperforin against breast cancer cells: identification of cell death and autophagy pathways ( Consultant)
  26. 2016 - 2019, Fundamental Research Grant Scheme (FRGS)
    The role of fibroblast on microRNA regulation of epithelial to mesenchymal transition-mediated cisplatin resistance in bladder cancer ( Consultant)
  27. 2017 - 2019, Fundamental Research Grant Scheme (FRGS)
    Mechanistic basis of tumor evasion from cytotoxic T cells (CTL) surveillance in pancreatic cancers ( Consultant)
  28. 2017 - 2019, Fundamental Research Grant Scheme (FRGS)
    Nano-stealthing the STAT3-blocker for improved anti-metastatic activity: mechanistic and pharmacological studies ( Consultant)
  29. 2017 - 2019, Geran Penyelidikan Universiti Malaya (UMRG)
    Regulation of cell motility by cancer-associated fibroblasts to induce stemness traits in endometrial cancer ( Principal Investigator(PI))
  30. 2015 - 2018, Geran Penyelidikan Universiti Malaya (UMRG)
    Investigating the role of miR-548m in epithelial-mesenchymal transition of cancer metastasis ( Consultant)
  31. 2015 - 2018, Fundamental Research Grant Scheme (FRGS)
    Differential pharmacological actions of medroxyprogesterone acetate on benign and cancer- associated endometrial fibroblasts ( Principal Investigator(PI))
  32. 2016 - 2018, Fundamental Research Grant Scheme (FRGS)
    Regulation of cancer cell epithelial-mesenchymal plasticity (EMP) by p53 gain-of-function mutations ( Consultant)
  33. 2014 - 2017, RU Operation
    Primary cell culture models for cancer drug discovery ( Principal Investigator(PI))
  34. 2014 - 2016, TechnoFund
    Building regional cells ( Principal Investigator(PI))
  35. 2013 - 2015, Geran Penyelidikan Universiti Malaya (UMRG)
    Role of cancer-associated fibroblasts in the progression of endometrial cancer ( Principal Investigator(PI))
  36. 2014 - 2014, High Impact Research (HIR)
    Obesity in Malaysian adolescent population: Prevalence, risk factors, complications and intervention ( Consultant)
  37. 2013 - 2014, Geran Penyelidikan Universiti Malaya (UMRG)
    Stromal fibroblasts as mediators for chemoresistance in oral carcinoma cells ( Consultant)
  38. 2013 - 2014, RU Operation
    Towards a successful career in cancer research ( Principal Investigator(PI))
  39. 2011 - 2013, High Impact Research (HIR)
    Targeting tumor-stellate cells interaction for novel therapeutics in pancreatic cancer ( Principal Investigator(PI))
  40. 2012 - 2013, Geran Penyelidikan Universiti Malaya (UMRG)
    Stromal fibroblasts as mediators of chemoresistance in oral carcinoma cells ( Consultant)
  41. 2012 - 2013, Geran Penyelidikan Universiti Malaya (UMRG)
    Molecular determinants underlying the progression of normal endometrium to endometriosis, endometrial cancer and ovarian cancer ( Principal Investigator(PI))
  42. 2011 - 2012, Geran Penyelidikan Universiti Malaya (UMRG)
    Molecular determinants underlying the progression of normal endometrium to endometriosis, endometrial cancer and ovarian cancer ( Principal Investigator(PI))
Private
  1. 2019 - 2022, Ministry of Education
    Role of liposome in stimulating exosome biogenesis and wound heaing, Mahsa University ( Co-Researcher)
International
  1. 2020 - 2023, International Funding
    Using Public Engagement To Enhance The Effectiveness Of Local Health Advisories For Environmental Pollution And Transboundary Haze ( Principal Investigator(PI))
  2. 2015 - 2016, International Funding
    Death and Disability: The vulnerability of older people in Malaysia to urbanization and climate change ( Consultant)

CONSULTANCY PROJECT

  • Technology Training Module On The Topic "a Review of Regulatory Landscape and Core Technologies Used in The Manufacturing Sector in Malaysia", PMO Innovations Sdn Bhd, Trainer
    22 Jan 2021 - 22 Jan 2021 (National)
  • Impact of Migrain On Productivity Among Working Population in Malaysia, Novartis (M) Corp, Consultant
    01 Dec 2018 - 01 Dec 2019 (National)
  • Impact of Migraine On Productivity Among Working Population in Malaysia, Novartis (M) Corporation
    01 Dec 2018 - 01 Dec 2019 (National)
  • In-Depth Understanding of The Economic Concerns in Breast and Cervical Cancer Patients., AIA Berhad
    01 Jan 2018 - 01 Jan 2019 (National)
  • Examiner for Phd Candidate - Sharmila Velapasamy, University of Malaya
    01 Dec 2014 - 01 Dec 2014 (National)
  • Lead Scientist, Cancer Cell Culture Facility-Umcri, University of Malaya Cancer Research Institute
    01 Dec 2011 - 01 Dec 2014 (National)
  • Examiner for Phd Candidate - Oh Li Xian, University of Malaya
    01 Dec 2014 - 01 Dec 2014 (National)
  • Evaluator for Frgs, University of Malaya
    01 Dec 2014 - 01 Dec 2014 (National)
  • Evaluator for Sciencefund, University of Malaya
    01 Dec 2014 - 01 Dec 2014 (National)
  • Speaker for Orthopaedic Research Symposium At Malaysian Orthopaedic Association Scientific Meeting, Malaysian Orthopaedic Association
    01 Dec 2014 - 01 Dec 2014 (National)
  • Evaluator for Umrg, University of Malaya
    01 Dec 2014 - 01 Dec 2014 (National)
  • Judge Panel for Malaysian Orthopaediac Association Scientific Meeting, Malaysian Orthopaediac Association
    01 Dec 2014 - 01 Dec 2014 (National)
  • Sub-Editor for The Journal of University of Malaya Medical Center, The Journal of University of Malaya Medical Center
    01 Dec 2012 - 01 Dec 2013 (National)
  • Examiner for Msc Thesis - Tay Liang Xian, Faculty of Medicine, University of Malaya
    01 Dec 2013 - 01 Dec 2013 (National)
  • Judge Panel, Malaysian Society for Molecular Biology and Biotechnology
    01 Dec 2012 - 01 Dec 2012 (National)
  • Facilitator, Editing Your Manuscript for Publication: Workshop for Postgraduate Students, Faculty of Medicine, University of Malaya
    01 Jan 2012 - 01 Jan 2012 (National)
  • Examiner for Phd Candidate Candidature Defense, Department of Pharmacology, Faculty of Medicine, University of Malaya
    01 Jan 2011 - 01 Jan 2011 (National)

PAPER PRESENTED

INVITED SEMINAR
  1. Harnessing Tumor-Stroma Interaction for Cancer Drug Discovery, Potential Therapies in Cancer, PLT Scientific Sdn Bhd (National) (02 Oct 2019 - 02 Oct 2019)
INVITED SPEAKER
  1. Talent Development for Technology Transfer: A University's Perspective, Workshop on Catalyzing Quality STI Demand Raised by the Demand-side of Technology Commercialization, Asia-Pacific Economic Cooperation Third Senior Official's Meeting (International) (08 Aug 2023 - 08 Aug 2023)
  2. Targeting Cellular and Nutrient Microenvironment for Cancer Therapy, Bridging Translational Cancer Research in conjunction with the World Cancer Day, Universiti Malaya Cancer Research Institute (National) (03 Mar 2020 - 03 Mar 2020)
  3. Targeting metabolic vulnerabilities in breast cancer, 31st Annual Scientific Congress of Malaysian Oncological Society, Malaysian Oncological Society (National) (01 Nov 2019 - 03 Nov 2019)
  4. Human cancer models - the good, bad and the ugly, Cell culture solutions for research, Biomedia SPD Scientific (University) (31 Jul 2019 - 31 Jul 2019)
  5. Local grant opportunities in Malaysia, Research Proposal Writing Workshop, Clinical Research Malaysia (National) (19 Jun 2019 - 20 Jun 2019)
  6. Effects of medroxyprogesterone acetate (MPA) in activating progesterone receptor signaling in benign and cancer-associated fibroblasts of the endometrium , 14th Asia-Pacific Oncologists Annual Meeting , Journal of Cancer Science & Therapy (International) (20 Nov 2017 - 22 Nov 2017)
  7. Fibroblasts and their enigmatic roles in endometrial cancer progression, Visit to Institute of Advanced Biosciences, University of Grenoble Alps, University of Grenoble Alps (International) (09 Dec 2016 - 09 Dec 2016)
  8. Interleukin-6 secreted by cancer-associated fibroblasts induces endometrial cancer growht, 13th Asia-Pacific Oncologists Annual Meeting, Conference Series LLC (International) (17 Oct 2016 - 19 Oct 2016)
  9. Advanced Prostate Cancer: Journey to Resistance , 1st Ova-Pros Standalone Meeting, Johnson&Johnson (National) (06 Jun 2015 - 06 Jun 2015)
  10. Chemoresistance in Osteosarcoma, 44th Malayasian Orthopaedic Association Annual Scientific Meeting (International) (29 May 2014 - 01 Jun 2014)
  11. Targeting the fibroblasts in the microenvironment of endometrial cancer, 24th National Scientific Conference, Malaysian Institute of Medical Laboratory Sciences, Malaysian Institute of Medical Laboratory Sciences (National) (03 Sep 2013 - 05 Sep 2013)
EVENT ORGANISER
  1. Bone Metastasis: A Priming Role by Tumor Stroma, 45th Malaysian Orthopaedic Association Annual Scientific Meeting, Malaysian Orthopaedic Association (National) (22 May 2015 - 24 May 2015)
  2. Harnessing tumor-stroma interaction for cancer drug discovery, FOM Research Week 2015, Departments of Pharmacology and Pharmacy (University) (11 May 2015 - 15 May 2015)
  3. University of Malaya-Longwood Medical International Foundation Short Course on Translational Medicine, University of Malaya-Longwood Medical International Foundation Short Course on Translational Medicine (National) (08 Dec 2014 - 12 Dec 2014)
  4. Recent Updates in Cancer Research and Drug Discovery, Pharmacology & Physiology International Scientific Congress 2014 (22 Aug 2014 - 24 Aug 2014)
POSTER PRESENTER
  1. Cancer-associated fibroblasts induce c-myc expression in endometrial cancer through interleukin-6 signaling, Cell-VIB Conference: Hallmarks of Cancer, Cell Press (International) (11 Dec 2016 - 13 Dec 2016)
  2. Cancer-associated fibroblasts promote endometrial cancer cell proliferation in vitro and in vivo, American Association for Cancer Research Annual Meeting 2014, American Association for Cancer Research (International) (05 Apr 2014 - 09 Apr 2014)
OTHERS
  1. Mahmood Merican Award , 44th Malaysian Orthopaedic Association Annual Scientific Meeting  (International) (29 May 2014 - 01 Jun 2014)

ACADEMIC/PROF. SERVICES

Evaluation
  1. (2024) Frgs Internal Reviewer, University, (Reviewer)
  2. (2024) Panel, Proposal Enhancement Unit, Ippp, University, (Reviewer)
  3. (2023) External Reviewer, Frgs At Taylor University, National, (Reviewer)
  4. (2023) Hari Inovasi Forest Research Institute Malaysia (Frim), National, (Reviewer)
  5. (2023) Internal Examiner for Phd Candidate, Gan Chai Phei, University, (Internal Examiner)
  6. (2023) 4th Selangor R&D & Innovation Expo (Srie) 2023, University, (Reviewer)
  7. (2023) Frgs Kpt Panel Reviewer, National, (Reviewer)
  8. (2022) Judge for Impres Conference, International, (Reviewer)
  9. (2022) External Examiner for Veerasamy Tarmarajen from Sunway University, National, (External Examiner)
  10. (2022) Jury for The Best Intelligence Figures in Malaysia, National, (External Evaluator)
  11. (2022) "Mir-548k Suppresses Apoptosis in Breast Cancer Cells by Affecting Pten/Pi3k/Akt Signaling Pathway, International, (Reviewer)
  12. (2022) Grant Reviewer for Dana Penyelidikan Kementerian Pengajian Tinggi, National, (External Evaluator)
  13. (2021) Judge, International Digital Innovation in Wellness Exhibition, International, (External Evaluator)
  14. (2021) Judge, Molecular Medicine Postgraduate Students (Mompes) 1st Scientific Symposium, National, (Internal Evaluator)
  15. (2021) Reviewer for Drug Design, Development and Therapy Manuscript Id341125, International, (Reviewer)
  16. (2021) Reviewer for Anti-Cancer Agents in Medicinal Chemistry Article Bms-Acamc-2021-271, International, (Reviewer)
  17. (2020) Experimental Cell Research, (Reviewer)
  18. (2020) Cancer Management and Research, (Reviewer)
  19. (2020) Panel Reviewer for UMSC C.A.R.E. Fund cycle 1/2020 , (Reviewer)
  20. (2020) Master of Science thesis - Alan Yaw from IMU , (External Examiner)
  21. (2020) Reviewer -Fundamental Research Grant for University Taylor's , (Reviewer)
  22. (2020) Reviewer - Italian Ministry of Health National Biomedical Research Call , (Reviewer)
  23. (2019) PhD candidature defense (GanChai Phei), (Internal Examiner)
  24. (2018) Italian Ministry of Health Research Grants, (Reviewer)
  25. (2018) Dato' Merican Research Grant Award, (Reviewer)
  26. (2018) PhD thesis - Ganesh P Vythilingam, (Internal Examiner)
  27. (2018) Faculty of Medicine Research Grants, (Reviewer)
  28. (2018) UM Living Lab Program, (Reviewer)
  29. (2018) Candidature defense - PhD (Nur Musfirah Binti Mahmud), (Internal Examiner)
  30. (2017) Taylor's University Conference Papers , (Reviewer)
  31. (2017) UMRG, Frontier Research Cluster, (Reviewer)
  32. (2017) UM Research Grants, (Reviewer)
  33. (2016) PhD thesis - Sahya Narayanan Patmanathan, (Internal Examiner)
  34. (2016) Italian Ministry of Health Research Grants, (Reviewer)
  35. (2016) PhD conversion - Khor Eng Soon, (Internal Examiner)
  36. (2016) PhD conversion - Hak Savatey, (Internal Examiner)
  37. (2016) LRGS Grants, Ministry of Higher Education, (Reviewer)
  38. (2016) BKP grants, (Reviewer)
  39. (2016) Fundamental Research Grant, MOE, (Reviewer)
  40. (2015) FRGS grants 2015, (Reviewer)
  41. (2015) Sciencefund, Ministry of Science, Technology & Innovation , (Reviewer)
  42. (2015) Taylor's University Research Grant, (Reviewer)
  43. (2015) Candidature defense (PhD) - Sathya Patmanathan, (Internal Examiner)
  44. (2014) Candidature defense (PhD) - Lim Siang Hui, (Internal Examiner)
  45. (2014) PhD thesis - Tan Boon Shing (IMU), (External Examiner)
  46. (2014) PhD proposal - Lai Sook Ling, (Internal Examiner)
  47. (2014) PhD proposal - Sharmila A/P Velapasamy, (Internal Examiner)
  48. (2014) UM Research Grant projects for Frontier Science Research Cluster, (Reviewer)
  49. (2014) Master of Medical Science - Soo Sian Siu, (Internal Examiner)
  50. (2014) Proposal seminar - Oh Li Xian, (Internal Examiner)
  51. (2013) Candidature defense (PhD) - Chong Pan Pan, (Internal Examiner)
  52. (2013) Master of Medical Science - Tay Liang Xin, (Internal Examiner)
  53. (2013) Candidature defense (MSc) - Krishnamurity Ganesan, (Internal Examiner)
  54. (2013) Candidature defense (MSc) - Tay Liang Xin, (Internal Examiner)
  55. (2013) Candidature defense (MSc) - Wee Ai Sze, (Internal Examiner)
  56. (2013) Italian Ministry of Health Research Grants, (Reviewer)
  57. (2013) Grant reviewer, National Science Center Poland, (Reviewer)
  58. (2013) Master of Medical Science - Wee Ai Tze, (Internal Examiner)
Contribution to external organisation
  1. (2023) Partner Organization of Event, International, (Resource Person)
  2. (2023) Speaker and Organization of Event, International, (Resource Person)
  3. (2022) Bengkel Perincian Pelan Tindakan Di Bawah Pelan Hala Tuju Pembangunan Vaksin Negara, National, (Expert Advisor)
  4. (2022) Guest Speaker for Malaysia Influential Educators Ceremony, National, (Resource Person)
  5. (2020) Reviewer for UMCARES grants, Universiti Malaya, University
  6. (2020) Editorial Board Member, Journal of Translational Medicine, National
  7. (2020) Organizing Committee Member, Global Summit on Cell Science and Molecular Biology 2021, The Scientistt, International
  8. (2020) Reviewer for TRGS application, Universiti Malaya, University
  9. (2020) Resource Person, PATHw Virtual Asia Roundtable on "Reimagining Healthier Workplaces in Asia", Novartis Healthcare Philippines
  10. (2020) Resource Person to a local magazine CeriaSihat, CeriaSihat
  11. (2019) Expert Advisor, Potential Therapies in Cancer, PLT Scientific Sdn Bhd, National
  12. (2019) Judge for Poster Session, Malaysian Society of Pharmacology and Physiology, National
  13. (2019) Scientific Committee, 33rd MSPP Scientific Meeting, Malaysian Society of Pharmacology & Physiology, National
  14. (2019) Resource Person, Cell culture solutions for Research, SPD Biosciences, University
  15. (2019) Chair, Plenary Lecture fro 33rd MSPP Scientific Meeting, Malaysian Society of Pharmacology & Physiology, National
  16. (2018) Malaysian Code of Responsible Conduct in Research, Prime Minister Office, National
  17. (2018) Industry-Academia Dialogue with YB Dato' Seri Haji Idris Jusoh, Ministry of Higher Education
  18. (2018) Mycofluor mycoplasma screening test, University of Malaya
  19. (2017) Precision Medicine Symposium, Institute Kanser Negara & Novartis Malaysia Sdn Bhd, National
  20. (2017) Organizing Committee, 14th Asia Pacific Oncologist Annual Meeting, Asia Pacific Oncologist Annual Meeting
  21. (2017) UM-Academia Sinica Research Symposium , University of Malaya and Academia Sinica
  22. (2017) Symposium on Sustainable Development, University of Malaya
  23. (2016) Speaker & mentor, 11th National Gathering of Pharmacy Students (NoGAPS) Educational Workshop, National Gathering of Pharmacy Students (NoGAPS), National
  24. (2016) 13th Asia Pacific Oncologist Annual Meeting , Asia Pacific Oncologist Annual Meeting
  25. (2016) Cell culture hands-on training, University of Malaya
  26. (2015) University of Malaya Research Carnival, University of Malaya
  27. (2015) Faculty of Medicine Research Week, University of Malaya
  28. (2015) 45th Malaysian Orthopaedic Association Annual Scientific Meeting, Malaysian Orthopaedic Association
  29. (2014) Judge, 44th Malaysian Orthopaedic Association Annual Scientific Meeting, National
  30. (2014) Chair, Pharmacology & Physiology International Scientific Congress, International
  31. (2014) Exco member, Malaysian Society of Pharmacology & Physiology, National
  32. (2014) Public Private Research Network, Cell Tissue Technology Sdn Bhd, National
  33. (2014) Scientific writing seminar, University of Malaya
  34. (2014) Science Workshops for Kazakhstan Students, Science Bridge Academia
  35. (2014) Short Course on Translational Medicine, UM and Longwoord Medical International Foundation
  36. (2013) Editor, Journal of Health and Translational Medicine
  37. (2012) 19th Scientific Meeting Postgraduate Oral Presentation Competition, Malaysian Society for Molecular Biology and Biotechnology, National
  38. (2012) The Schoolwide Enrichment Model Pogram, MRSM Tun Ghafar Baba, National
  39. (2012) Editing your manuscript for publication workshop for postgraduate students, University of Malaya
  40. (2011) Cancer Cell Culture Facility, UM Cancer Research Institute
Contribution to event
  1. (2024) Committee Member, University, (Event Organiser)
  2. (2023) Moderator and Participant, International, (Participant)
  3. (2023) Panel Reviewer, International, (Panelist/Moderator)
  4. (2023) Participation, International, (Participant)
  5. (2023) Organizing Committee, National, (Event Organiser)
  6. (2022) Scientific and Sponsorship Committee, International, (Event Organiser)
  7. (2022) Panel, Bringing Your Innovation to The Next Level - Why and How, University, (Panelist/Moderator)
  8. (2022) Scientific Committee, International, (Event Organiser)
  9. (2022) Panel for Sti Development Opportunities for Youth, Women and Msme, International, (Panelist/Moderator)
  10. (2021) Moderator, Covid-19 is Shifting from Pandemic to Endemic - But What Does That Mean for Higher Education Institutions?, International, (Panelist/Moderator)
  11. (2021) Moderator, The Future of Research Laboratories Post Covid-19 Pandemic, International, (Panelist/Moderator)
  12. (2021) Lecture "The Tale of Fibroblasts in Endometrial Cancer", International, (Course Facilitator)
  13. (2021) Participant in Asean Virtual Tourism and Culture Exposure, International, (Participant)
  14. (2021) Participant in Asean Leader Sharing, International, (Participant)
  15. (2021) Panelist to U.S.-Asean Internship Webinar, International, (Panelist/Moderator)
  16. (2020) Moderator, Water Security, International, (Panelist/Moderator)
  17. (2020) Moderator, Crossing The Valley of Death: Opportunities for Medical Device Innovation, International, (Panelist/Moderator)
  18. (2019) Committee, International, (Event Organiser)
Mentoring
  1. (2022) Final Year Student Supervisor, University, (Mentor)
  2. (2021) Course Coordinator for Mid1009, University, (Mentor)
  3. (2021) Biomedical Science Final Year Students, University, (Mentor)
  4. (2016) Course Coordinator for Mtej1116, University, (Mentor)
  5. (2016) Course Coordinator for Biomedical Science 2014-2016, University, (Mentor)

SUPERVISION

Postgraduate Student
PhD/ Doctoral
  1. (2024) UNRAVELING TH EROLE OF ENDOMETRIAL CANCER FIBROBLASTS IN LIPOGENIC-DRIVEN DRUG RESISTANCE IN OBESE WOMEN USING METABOLIC FINGERPRINTING APPROACH., YEU TZE HUA
  2. (2024) Cytoprotective effects of Lignosus rhinocerotis against L-Buthionine-sulfoximine induced oxidative damage in Friedreich's ataxia fibroblast, MICHAEL WENG LOK PHANG
  3. (2024) The Role of miR-143/miR-145 Cluster in Obesity-associated Colorectal Cancer, WAN MUHAMMAD FARHAN SYAFIQ BIN WAN MOHD NOR
  4. (2023) Cancer-Associated Fibroblasts Induce A Differential Expression Of E-Cadherin Via Hsa-Let-7b-5p In A Cisplatin-Resistant Bladder Cancer Model., YOGAAMBIKAI A/P PARAMANANTHAM
  5. (2021) ABNORMAL PROGESTERONE RECEPTOR SIGNALING IN ENDOMETRIAL CANCER-ASSOCIATED FIBROBLASTS CONTRIBUTES TO MEDROXY PROGESTERONE ACETATE RESISTANCE IN ENDOMETRIAL CANCER, INTAN SOFIA OMAR
  6. (2021) A KINASE shRNA LIBRARY SCREENING TO IDENTIFY PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDPK1) AND JANUS-KINASE 1 (JAK1) AS POTENTIAL TARGETS FOR TREATMENT OF PROSTATE CANCER, GEETHA A/P NALAIRNDRAN
  7. (2020) THE ROLE OF FIBROBLAST IN THE MICRO RNA REGULATION CISPLATIN RESISTANCE IN BLADDER CANCER, YOGAAMBIKAI PARAMANANTHAM
  8. (2020) Identification of New Molecular Targets in Androgen-Independent Prostate Cancer Using High-Throughput Kinase shRNA Library Screen.CTED DEVELOPED AUSTRALASIAN MARKETS, GEETHA NALAIRNDRAN
  9. (2020) Differential Effects of Progesterone Receptor Signaling in benign-and Cancer-Associated Fibroblasts of the Endometrium., INTAN SOFIA OMAR
  10. (2020) Cytoprotective effects of Lignosus rhinocerotis against L-Buthionine-sulfoximine induced oxidative damage in Friedreich's ataxia fibroblast, Michael Weng Lok Phang
  11. (2019) THE ROLE OF FIBROBLAST IN THE MICRO RNA REGULATION CISPLATIN RESISTANCE IN BLADDER CANCER, YOGAAMBIKAI PARAMANANTHAM
  12. (2019) METABOLIC ROLE OF FATTY ACID BINDING PROTEIN 7 IN MEDIATING TRIPLE NEGATIVE BREAST CANCER CELL DEATH, KWONG SOKE CHEE
  13. (2019) METABOLIC ROLE OF FATTY ACID BINDING PROTEIN 7 IN MEDIATING TRIPLE NEGATIVE BREAST CANCER CELL DEATH, KWONG SOKE CHEE
  14. (2018) Identification of New Molecular Targets in Androgen-Independent Prostate Cancer Using High-Throughput Kinase shRNA Library Screen., GEETHA NALAIRNDRAN
  15. (2018) Differential Effects of Progesterone Receptor Signaling in benign-and Cancer-Associated Fibroblasts of the Endometrium., INTAN SOFIA OMAR
  16. (2017) THE ROLE OF COLLAGEN-DISCOIDIN DOMAIN RECEPTOR 1 IN HPV-POSITIVE AND -NEGATIVE HEAD AND NECK CANCER, LAI SOOK LING
  17. (2017) THE ROLE OF COLLAGEN-DISCOIDIN DOMAIN RECEPTOR 1 IN HPV-POSITIVE AND -NEGATIVE HEAD AND NECK CANCER, LAI SOOK LING
  18. (2016) Pancreatic Stellate Cell Secretion and Interleukin-6 Regulate Pancreatic Cancer Cell Proliferation and Epithelial-mesenchymal Transition Through Nuclear Factor Erythroid-2., WU YUAN SENG
  19. (2016) MIXED OLEIC ACID STEALTH LIPOSOMES FOR ANTICANCER DRUG DELIVERY, VICIT RIZAL A/L EH SUK
  20. (2016) MATHEMATICAL MODELING OF THE TUMOR CELLS POPULATION DYNAMICS IN BREAST CANCER, AMIN OROJI
  21. (2016) MATHEMATICAL MODELING OF THE TUMOR CELLS POPULATION DYNAMICS IN BREAST CANCER, AMIN OROJI
  22. (2016) Pancreatic Stellate Cell Secretion and Interleukin-6 Regulate Pancreatic Cancer Cell Proliferation and Epithelial-mesenchymal Transition Through Nuclear Factor Erythroid-2., WU YUAN SENG
  23. (2016) MIXED OLEIC ACID STEALTH LIPOSOMES FOR ANTICANCER DRUG DELIVERY, VICIT RIZAL A/L EH SUK
  24. (2015) ONCOGENIC ROLE OF CANCER-ASSOCIATED FIBROBLAST SECRETION IN ENDOMETRIAL CANCER PROGRESSION IN VITRO AND IN VIVO., KAVITA A/P S.SUBRAMANIAM
  25. (2015) ONCOGENIC ROLE OF CANCER-ASSOCIATED FIBROBLAST SECRETION IN ENDOMETRIAL CANCER PROGRESSION IN VITRO AND IN VIVO., KAVITA A/P S.SUBRAMANIAM
  26. (2014) Dose- And Time Dependent Effects Of Oil-Palm (Elaeis Guineensis) Leaf Extract in Streptozotocin-Induced Oxidative Stress And Renal Damage In Diabetic Rats., VARATHARAJAN RAJAVEL
Master
  1. (2024) The Role of Cholesterol-Anionic Liposomes in Stimulating Extracellular Vesicles Secretion in Mesenchymal Stem Cells, JZIT WEII CHEN
  2. (2023) The Role of PPARα and PKC-mediated Lipid Signaling towards Selective Palmitate-induced Cytotoxicity in Endometrial Cancer Cell Lines’., AZILLEO KRISTO MOZIHIM
  3. (2022) Establishing Raman Spectra to Detect Lipid Metabolism in Endometrial Cancer associated Fibroblasts (CAFs) in Obese Women, YEU TZE HUA
  4. (2021) REGULATION OF ENDOMETRIAL CANCER CELL MIGRATION BY CANCER-ASSOCIATED FIBROBLASTS IN A 3D ENVIRONMENT, YAP CHEE VOON
  5. (2020) IMPROVING THE ANTI-METASTATIC CANCER EFFICACY OF THE STAT3 PROTEIN DIMERISATION BLOCKERS THROUGH THE USE OF MICELLAR NANO-DRUG-CARRIERS, KWA YEE CHU
  6. (2020) IMPROVED ANTI-METASTATIC EFFICACY OF STATTIC THROUGH POLYMERIC MICELLAR AND ALBUMIN-BASED NANO-DELIVERY SYSTEMS: IN VITRO STUDIES, KWA YEE CHU
  7. (2020) Investigating the Role of MIR-548M in Epithelial-Mesenchymal Transition of Breast Cancer Metastasis, WAN MUHAMMAD FARHAN SYAFIQ BIN WAN MOHD NOR
  8. (2018) The role of Cancer-associated Fibroblasts in Endometrial Cancer Cells Matility and Contractility, YAP CHEE VOON
  9. (2018) Investigating the Role of miR-548m in Epithelial-mesenchymal Transition of Cancer Metastasis, WAN MUHAMMAD FARHAN SYAFIQ BIN WAN MOHD NOR
  10. (2018) IMPROVING THE ANTI-METASTATIC CANCER EFFICACY OF THE STAT3 PROTEIN DIMERISATION BLOCKERS THROUGH THE USE OF MICELLAR NANO-DRUG-CARRIERS, KWA YEE CHU
Under Graduate Students
  1. (2022) The role of microRNA-181d-5p in the palmitic acid-treated colorectal cancer cell and its effects on cancer progression
  2. (2022) The role of microRNA-143 in the palmitic acid-treated colorectal cancer cell and its effects on cancer progression
  3. (2021) The role of Galectin-1 in endometrial cancer-associated fibroblasts and its effect on endometrial cancer proliferation and migration
  4. (2021) THE FORMATION AND CHARACTERIZATION OF METHYL GALLATE-OLEIC ACID LIPOSOMES
  5. (2021) STUDY OF THE FORMATION AND PHYSICOCHEMICAL PROPERTIES OF CHITOSAN-COATED OLEIC ACID LIPOSOMES AS A POTENTIAL MUCOADHESIVE DRUG DELIVERY
  6. (2021) Modulatory Role of Galectin-3 in the Endometrial CAFs on Endometrial Cancer Proliferation and Migration

TEACHING

Master
  1. (2019) MBBS - Postgraduate
  2. (2017) MBBS - Postgraduate
  3. (2015) MBBS - Postgraduate
  4. (2014) MBBS - Postgraduate
  5. () MBBS - Postgraduate
Bachelor
  1. (2021) MIC3010 - Advances in Medical Pharmacology
  2. (2021) MIX3003 - Drugs: from Target to Market
  3. (2021) DIA2006 - Pharmacology
  4. (2021) MID1009 - Pharmacology in Nursing
  5. (2021) MIC2004 - Principles in Pharmacology and Toxicology
  6. (2021) UMMP - Ummp Stage 1,2 and 3.3
  7. (2021) UMMP - Universiti Malaya Medical Programme
  8. (2020) MIX3003 - Drugs from Target to Market
  9. (2020) DIA2006 - Pharmacology
  10. (2020) MID1009 - Pharmacology in Nursing
  11. (2020) MIC2004 - Principles in Pharmacology and Toxicology
  12. (2019) MIC3010 - Advances in Medical Pharmacology
  13. (2019) UMMP PBL - Block 11 Oncology and Paliative Care
  14. (2019) MIX3003 - Drugs from Target to Market
  15. (2019) DIA2006 - Pharmacology
  16. (2019) MIC2004 - Principles in Pharmacology and Toxicology
  17. (2019) DIA2006 - Pharmacology
  18. (2019) MIC3010 - Advances in Medical Pharmacology
  19. (2019) MID1009 - Pharmacology in Nursing
  20. (2019) UMMP - Stage 2
  21. (2018) DIA2006 - Pharmacology
  22. (2018) UMMP - Stage 2
  23. (2016) MBEB4401 - Dna Cloning Techniques
  24. (2016) UMMP - Stage 2
  25. (2015) DNED2101 - Farmakologi
  26. (2015) DNED2101 - Farmakologi
  27. (2015) MBBS - Phase 3
  28. (2015) MBEB2105 - General Principles in Pharmacology and Toxicology
  29. (2015) MTEJ2112 - Basic Medical Science Iv
  30. (2015) MWEF2103 - Central Nervous System & Therapy
  31. (2015) UMMP - Stage 2
  32. (2014) DNED2101 - Farmakologi
  33. (2014) DNED2101 - Farmakologi
  34. (2014) MBBS - Pharmacology
  35. (2014) MBBS - Phase 2 Pharmacology
  36. (2014) MBBS - Phase 3
  37. (2014) MBEB2105 - General Principles in Pharmacology and Toxicology
  38. (2014) MTEJ1116 - Pharmacology and Handling of Medication
  39. (2014) MTEJ2112 - Basic Medical Science Iv
  40. (2013) Pharmacology MBBS Phase 2
  41. (2013) DNED2101 - Farmakologi
  42. (2013) MBBS - Phase 2 Pharmacology
  43. (2012) DNED2101 - Farmakologi
  44. (2012) MBBS - Phase 2 Pharmacology
  45. (2012) MTEJ1116 - Pharmacology and Handling of Medication
  46. (2011) DNED2101 - Farmakologi
  47. (2011) MBBS - Phase 2 Pharmacology
  48. (2011) MBEB2105 - General Principles in Pharmacology and Toxicology
  49. (2011) MWEF2103 - Central Nervous System & Therapy
  50. () MIC3010 - Advances in Medical Pharmacology
  51. () MID1009 - Pharmacology in Nursing

PATENT/IPR

  • IP Training Module: Trademark
    COPYRIGHT
  • IP Training Module: Fundamentals of Intellectual Property
    COPYRIGHT
  • IP Training Module: Copyright
    COPYRIGHT
  • Volume 1 - Guidebook For Researchers to Evaluate the Patent Protection of Their Proposed Inventions in the Field of Engineering
    COPYRIGHT
  • IP Training Module: Industrial Design & Patent Rights
    COPYRIGHT
  • Volume 2 - Guidebook For Researchers To Evaluate The Patent Protection Of Their Proposed Inventions In The Field Of Information and Communication Technology (ICT)
    COPYRIGHT
  • Volume 3 - Guidebook For Researchers To Evaluate The Patent Protection Of Their Proposed Inventions In The Field Of Health Science
    COPYRIGHT
  • Volume 4 - Guidebook For Researchers To Evaluate The Patent Protection Of Their Proposed Inventions In The Field Of Science
    COPYRIGHT
  • Product Sheet for Human Primary Endometriosis Cells
    COPYRIGHT
  • Product Sheet for Human Primary Ovarian Cancer Cells
    COPYRIGHT
  • Product Sheet for Human Primary Cervical Cancer Cells
    COPYRIGHT
  • Malaysian Renal Cell Carcinoma cell lines
    COPYRIGHT
  • Renal Cell Carcinoma cell line establishment
    COPYRIGHT

COMMERCIALIZATION

  • Primary cancer cells, (Product)

SOCIAL RESPONSIBILITY ACTIVITIES

  • Advisor for Institute of International Intellectual Property Certified Institute, (05 Oct 2022 - 05 Oct 2024) (National)
  • Advisor, National Consumer Action Council, (04 Oct 2022 - 04 Oct 2024) (National)
  • Advisor for National Empowerment Education Council, (04 Oct 2022 - 04 Oct 2024) (National)
  • Director, Obesity Awareness Week, (28 Mar 2022 - 01 Apr 2022) (National)
  • Contributer to The Article in Mims Doctor: Migraine Linked to Workplace Absenteeism, Presenteeism, (24 Nov 2020 - 24 Nov 2020)
  • Resource Person to a Local Magazine, Ceriasihat, (11 Nov 2020 - 31 Dec 2020) (National)
  • Participant, Stakeholder Engagement Workshop for Open Science Organized by Academi Sains Malaysia, (04 Jun 2020 - 04 Jun 2020)
  • Director, Mykidney Program, (19 Feb 2019 - 18 Feb 2021) (National)
  • Moderator, Academia-Industry Forum, UM Research Carnival, (16 Nov 2018 - 16 Nov 2018)
  • Panelist, 6th Asean Future Leaders Summit (Afles), (27 Jul 2018 - 27 Jul 2018)
  • Organizing Commitee, 14th Asia-Pacific Oncologists Annual Meeting, (20 Nov 2017 - 22 Nov 2017)
  • Volunteer for Konvensyen Komuniti Sihat Pembina Negara (Kospen) Peringkat Kebangsaan 2017, (19 Sep 2017 - 20 Sep 2017)
  • Expert Panel for Italian Ministry of Health Research Grant, (14 Nov 2016 - 31 Mar 2017)
  • Organizing Committee, 13th Asia-Pacific Oncologists Annual Meeting, (17 Oct 2016 - 19 Oct 2016)
  • Speaker for 11th National Gathering of Pharmacy Students (Nogaps) Education Workshop, (19 Aug 2016 - 21 Aug 2016)
  • Science Workshop for Kazakhstan Students (Scientific Outreach Program), (16 Dec 2014 - 24 Dec 2014)
  • Demand-Driven Innovation Project by Public-Private Research Network, (18 Nov 2014 - 18 Nov 2014)
  • Project Advisor, Schoolwide Enrichment Model, Mrsm Tun Ghafar Baba, (09 Aug 2012 - 01 Mar 2013)
  • Rapporteur for National Congress of Professor, (05 Jul 2011 - 08 Jul 2011)

COURSE ATTENDED

Internal / External Course
CONFERENCE
  1. PHARMACOLOGY & PHYSIOLOGY INTERNATIONAL SCIENTIFIC CONGRESS 2014, Putra World Trade Center, Kuala Lumpur (22 Aug 2014 - 24 Aug 2014)
  2. ASEAN UNIVERSITY START-UP CONFERENCE AND SHOWCASE 2015, Malaysia Design Development Center (Ddec), Kuala Lumpur (19 Nov 2015 - 21 Nov 2015)
  3. 45TH MALAYSIAN ORTHOPAEDIC ASSOCIATION ANNUAL SCIENTIFIC MEETING , Shangri-La Hotel, Kuala Lumpur (22 May 2015 - 24 May 2015)
  4. 6TH ANNUAL BIOPHARMA ASIA CONVENTION 2013, Resort World Sentosa Singapore (17 Mar 2013 - 20 Mar 2013)
  5. AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING 2014, San Diego Convention Center, San Diego, Ca (03 Apr 2014 - 11 Apr 2014)
  6. THE CELL-VIB SYMPOSIUM: HALLMARKS OF CANCER, Ghent (10 Dec 2016 - 15 Dec 2016)
  7. BASIC AND CLINICAL IMMUNOLOGY COURSE, University of Malaya (23 Jul 2013 - 27 Jul 2013)
  8. 14TH ASIA PACIFIC ONCOLOGISTS ANNUAL MEETING 2017, Melbourne, Australia (19 Nov 2017 - 24 Nov 2017)
  9. SATU PRESIDENTS' FORUM 2022 GENERAL ASSEMBLY, National Cheng Kung University, Taiwan (22 Nov 2022 - 25 Nov 2022)
INTERNAL COURSE- ORGANIZED BY PTJ
  1. PRA BENGKEL PENYEDIAAN MANUAL JENAMA UNIVERSITI MALAYA, Connexion Conference & Event Centre, Bangsar (13 Jan 2022 - 13 Jan 2022)
  2. BENGKEL HALA TUJU DAN PERANCANGAN PENYELIDIKAN DAN INOVASI, Concorde Hotel Shah Alam (07 Feb 2020 - 09 Feb 2020)
  3. WORKSHOP ON STORYTELLING 201 : BETTER STORIES IN NEW MEDIA, Seminar Room 1 & 2, Lobby, Research Management Innovation Complex, Ippp, UM (18 Aug 2020 - 18 Aug 2020)
  4. WORKSHOP ON VIDEO EDITING USING MICROSOFT PHOTOS, Via Google Meet (27 Nov 2020 - 27 Nov 2020)
  5. EMERALD FOR BASIC TEACHING AND LEARNING, Universiti Malaya (04 Nov 2019 - 08 Nov 2019)
  6. THE ART OF LIVING WITH DR. VENGA - THE SCIENCE OF PRODUCTIVITY: HOW TO GET MORE DONE IN A DAY, Auditorium Tj Danaraj Fakulti Perubatan (14 Sep 2017 - 14 Sep 2017)
  7. BENGKEL "DRAFTING PROPOSALS FOR ERASMUS + CAPACITY BUILDING FOR HIGHER EDUCATION" , Bilik Cube, Akademi Pengajian Islam (Api) (20 Aug 2019 - 21 Aug 2019)
  8. CURATION WORKSHOP: CURATING YOUR RESEARCH INTO STORY, Bilik Mesyuarat 2, Tingkat 4, Bangunan Canseleri (17 Jul 2019 - 18 Jul 2019)
  9. BENGKEL TEAM BUILDING, Asia Camp, Jalan Ampang Pechah, 44000 Kuala Kubu Baru, Selangor Darul Ehsan (16 Aug 2018 - 16 Aug 2018)
  10. CRL RESTRUCTURING WORKSHOP, Ve Hotel & Residences (03 Jul 2018 - 03 Jul 2018)
  11. "WORKSHOP ON COLLABORATION WITH CHINA" PADA 29 HINGGA 30 JANUARI 2018, Nexus Hotel, Bangsar, Kuala Lumpur (29 Jan 2018 - 30 Jan 2018)
EXTERNAL COURSE
  1. AKEPT LEADERSHIP TALK SERIES -1 SERIES, Kampus Akept Bandar Enstek Nilai (28 Feb 2017 - 28 Feb 2017)
  2. ASIA PACIFIC ASSOCIATION OF MEDICAL JOURNAL EDITORS CONVENTION NEW HORIZONS IN SCIENTIFIC WRITING AND PUBLISHING, Universiti Malaya (01 Sep 2012 - 02 Sep 2012)
  3. UNIVERSITY LEADERS ENTREPRENEURIAL EDUCATORS BOOTCAMP (UNILEEB), Elite Design Hotel, Kelantan (25 Nov 2019 - 28 Nov 2019)
  4. UNIVERSITY LEADERS ENTREPRENEURIAL EDUCATORS BOOTCAMP (UNILEEB), The Royal Widad @ Utmkl (09 Mar 2020 - 12 Mar 2020)
  5. UNIVERSITY LEADERS ENTREPRENEURIAL EDUCATORS BOOTCAMP (UNILEEB), Kuala Terengganu (21 Sep 2020 - 25 Sep 2020)
  6. SOCIAL ENTREPRENEURSHIP/SOCIAL INNOVATION TRAINER CERTIFICATION (SE/SI TRAINER CERTIFICATION), Online (26 Jun 2021 - 29 Jun 2021)
  7. INNOVATION POLICY DEVELOPMENT IN HIGHER EDUCATION TOWARDS HIGH INCOME NATION, Kampus Akept, Bandar Enstek, Negeri Sembilan (28 Oct 2013 - 29 Oct 2013)
  8. BEGINNING LINUX AND BIG DATA ANALYTICS, University of Malaya (27 Sep 2019 - 27 Sep 2019)
  9. 19TH SCIENTIFIC MEETING OF MALAYSIAN SOCIETY FOR MOLECULAR BIOLOGY AND BIOTECHNOLOGY, Universiti Malaya (31 Oct 2012 - 01 Nov 2012)
  10. MASO 2011 SCIENTIFIC CONFERENCE ON OBESITY"TOWARDS HEALTHY WEIGHT FOR LIFE", Seri Pacific Hotel Kuala Lumpur (28 Jun 2011 - 29 Jun 2011)
  11. HOW TO SUCCESSFULLY DESIGN PATHWAYS TO IMPACT FOR YOUR RESEARCH, University of Malaya (21 Aug 2019 - 21 Aug 2019)
  12. BASIC AND INTERMEDIATE IMPLEMENTATION SCIENCE WORKSHOP, University of Malaya (14 Aug 2019 - 15 Aug 2019)
  13. UM-LMIF TRANSLATIONAL MEDICINE SHORT COURSE, Sime Darby Convention Center (08 Dec 2014 - 12 Dec 2014)
  14. 1ST NATIONAL CONFERENCE ON CANCER, The Royale Chulan, Kuala Lumpur (08 Nov 2013 - 10 Nov 2013)
  15. AL101 QALB - GUIDED LEADERSHIP, Akademi Kepimpinan Pendidikan Tinggi, Bandar Enstek (16 Jul 2018 - 17 Jul 2018)
  16. BENGKEL GOOD CLINICAL PRACTICE, Fakulti Perubatan, Universiti Malaya (11 Dec 2012 - 13 Dec 2012)
  17. BD FACSARIA III OPERATION TRAINING COURSE, Universiti Malaya (03 Oct 2012 - 05 Oct 2012)
  18. 1ST REFRESHNER COUSE ON PHYSIOLOGY AND PHARMACOLOGY TEACHING, Faculti of Medicine & Healt Sciences,Universiti Putra Malaysia (24 May 2011 - 24 May 2011)
INTERNAL COURSE
  1. PROGRAM TRANSFORMASI MINDA, Aras 4, Bilik Senat Bangunan Canseleri (03 Sep 2019 - 06 Sep 2019)
COURSES ORGANIZED BY PTJ
  1. WORKSHOP ON DRAFTING PROPOSALS FOR ERASMUS+ CAPACITY BUILDING FOR HIGHER EDUCATION, University of Malaya (20 Aug 2019 - 21 Aug 2019)
  2. CURATION WORKSHOP: CURATING YOUR RESEARCH INTO STORY, Cancellory Building, University of Malaya (17 Jul 2019 - 18 Jul 2019)
  3. STATA WORKSHOP, University of Malaya (09 Jan 2012 - 10 Jan 2012)
RESEARCH
  1. 'HORMONE RESISTANCE IN CANCER', (08 Jun 2015 - 19 Jun 2015)
  2. 'HORMONE RESISTANCE IN CANCER', (11 Apr 2014 - 17 Apr 2014)